Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Arrow QuickFlash Catheterization Kit Recall Issued Following Reports of Life-Threatening Blood Vessel Damage At least 10 patient injuries and one death have been reported in connection to the Arrow QuickFlash catherization kit recall. April 8, 2024 Grace Muller Add Your Comments Federal safety officials warn that problems with the guidewire handles on ARROW catheterization kits could lead to serious and potentially life threatening damage to blood vessels, leading to the recall of more than 330,000 devices distributed throughout the United States between December 2021 and January 2024. The ARROW QuickFlash Catheterization Kits recall was posted by the U.S. Food and Drug Administration (FDA) on April 3, after the manufacturer received reports of at least 194 complaints, including 10 severe injuries and one death that appears to be related to the problem. The recalled ARROW QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits are designed for medical professionals to gain entry into a patient’s peripheral arterial system or smaller blood vessels. However, officials warn that increased resistance in the guidewire handle and chamber during use may lead to severe harm, including damage to the walls of blood vessels, constriction of blood vessels (known as vasospasm), blockages in arteries (embolism), or even fatalities. Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Port Catheter Lawsuit DID YOU OR A LOVED ONE RECEIVE AN IMPLANTABLE PORT CATHETER? Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Arrow Quickflash Catherization Kits Recall This recall affects approximately 334,995 Arrow QuickFlash Radial Artery and Radial Artery/Arterial Line Catheterization Kits that were distributed from December 1, 2021, to January 27, 2024. In a recall letter sent out to medical facilities and distributors on February 12, the manufacturers instructed medical facilities to immediately stop using and distributing the devices and to quarantine any remaining inventory. They advised distributors to provide a copy of the recall letter to customers who have purchased the recall products, and an acknowledgement that must be completed by customers. Any customers with any questions or concerns are advised to contact Teleflex and Arrow International at their Customer Service Phone: 1-866-396-2111, FAX: 1-855-419-8507 or Email: Recalls@teleflex.com. The FDA is allowing consumers to report any adverse reactions, side effects, or quality issues encountered during the use of these kits to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Tags: Arrow, Catheter Recall, Embolism, Teleflex Find Out If You Qualify for Port Catheter Compensation More Bard PowerPort Lawsuit Stories Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 November 26, 2025 Bard PowerPort Lawsuit MDL Tops 2,000 Cases September 17, 2025 Bard PowerPort Lawsuit Bellwether Trials Set To Begin March 2, 2026 August 26, 2025 0 Comments LinkedInThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (Posted: today) A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman’s wrongful death lawsuit. MORE ABOUT: DUPIXENT LAWSUITDupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025) Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: yesterday) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025) Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 6 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Drug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (Posted: today) A federal judge has given the makers of Dupixent until January 7 to respond to a Tennessee woman’s wrongful death lawsuit. MORE ABOUT: DUPIXENT LAWSUITDupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)Dupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025)
Depo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (Posted: yesterday) A federal judge has scheduled a series of case management conferences throughout 2026 as the parties prepare for five “pilot” bellwether trials, which are expected to begin in late 2026 or early 2027. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)Depo-Provera Pilot Lawsuit Deadlines in MDL Extended Approximately 6 Weeks (11/04/2025)
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: 6 days ago) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)